Stay current with the latest press releases from within the industry.
Release issued 11th January 2002
Media Alert for February 23 to March 1, 2002
Cambridge Healthtech Institute's Genome Tri- Conference To Attract Leading Experts as the Convergence of Genomics and Drug Discovery Transforms the Pharmaceutical Business
What: CHI's Genome Tri-Conference 2002…The Molecular Medicine Marketplace
Genomics is revolutionizing the drug discovery & development process. Learn about cutting-edge breakthroughs and applications at this weeklong event that includes programs on Genomic Partnering, Human Genome Discovery, and Gene Functional Analysis. The main exhibit hall with over 160 organizations is already sold out.
We invite members of the media to participate in the event, where you will interact with experts in genomics, proteomics, and bioinformatics. Representatives from leading pharmaceutical and biotech organizations, as well as government and academic institutions will be on hand.
When: Saturday, February 23 through Friday, March 1
Where: Santa Clara Convention Center 5001 Great America Parkway Santa Clara, California
Featured Presentations at the Genome Tri-Conference include:
At Genomic Partnering (February 23-24, 2002): Dr. Noubar B. Afeyan, Senior Managing Director and CEO, Flagship Ventures G. Steve Burrill, Chief Executive Officer, Burril & Company
At Human Genome Discovery (February 25-27, 2002): Dr. Lee Babiss, Head, Preclincial Research & Development, Hoffmann-La Roche, Inc. Dr. Maynard V. Olson, Professor of Genetics, University of Washington Dr. Leroy Hood, President and Director, Institute for Systems Biology Dr. Mihael Polymeropoulos, Novartis Pharmaceuticals Dr. Robert L. Strausberg, Director, Cancer Genomics Office, National Cancer Institute Dr. Andrew Lyall, IT Director and Chief Information Officer, Oxford GlycoSciences
At Gene Functional Analysis (February 28 - March 1, 2002): Dr. David Eisenberg, Director, U.S DOE Laboratory of Structural Biology and Molecular Medicine, Molecular Biology Institute, University of California, Los Angeles Dr. Karl K. Johe, Chairman and Chief Scientific Officer, Neuralstem, Inc.
Press Registration: By phone at 617-630-1300 or via the official event website www.genometriconference.com (click on press information). For additional information, event details, or to arrange interviews, please contact Dawn Peters at 617-630-1342
If you want to find out more about the company visit Cambridge Healthtech Institute profile.
(16th March 2001) CHI announces HUMAN PROTEOME PROJECT conference
(30th January 2001) CHI Announces GENOME TRI-CONFERENCE 2001
(2nd May 2000) CAMBRIDGE HEALTHTECH INSTITUTE Announces 7th Annual HIGH-THROUGHPUT TECHNOLOGIES 2000: Summit & Exposition
(21st April 2000) CAMBRIDGE HEALTHTECH INSTITUTE Announces BEYOND GENOME 2000
(3rd March 2000) CAMBRIDGE HEALTHTECH INSTITUTE Announces 2nd Annual PROTEIN DISCOVERY TECHNOLOGIES: New Methods and Applications in Therapeutic Development Conference